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Abstract. Nowadays, great achievements have been observed in the field of nanotechnology, 
especially in material science, supramolecular assemblies and drug delivery. In particular, the medical 
application of nanotechnologies, usually termed nanomedicine, has given a important push to the 
development of various types of drug-loaded nanocarriers, such as liposomes, nanoparticles, micelles etc. 
These systems able to serve as efficient diagnostic and/or therapeutic tools against heavy diseases, such 
as cancer, infectious or neurodegenerative disorders. Among the numerous classes of materials employed 
for drug delivery purposes, colloidal systems based on amphiphilic copolymers containing hydrophilic 
and hydrophobic segments have attracted much attention due to the possibility of synthesizing tunable 
chemical structures. Reversible addition fragmentation chain transfer (RAFT) polymerization is one of 
the most extensively studied controlled/living radical polymerization methods that can generate well-
defined polymers with targeted molecular weights characteristics, compositions and controlled 
architectures. RAFT technique has been effective employed to develop complex molecular architectures, 
such as blocks, gradient and stars copolymers. (Co)polymers based on N-vinyl succinimide (VSI) cause 
intense interest due to possibility of application as hydrophilic nontoxic materials in medicine. Such 
copolymers can be easily modified by alkaline hydrolysis resulting in conversion of VSI units to the 
Nvinyl succinimidic acid (VSA) units. Currently, cholesterol, as an essential component of the plasma 
membrane, has been known to be involved in many cellular processes such as membrane property 
regulation, steroidogenesis, bile acid synthesis and cellular signal transduction. 
In the present research a synthesis and investigation of novel promising nanocarriers based on 
amphiphilic copolymers with prolonged resistance to biodegradation was proposed. A series of novel 
gradient copolymers of N-vinyl succinimide and cholesterol (meth)acrylate were synthesized using RAFT 
polymerization. Copolymerization of monomers was conducted in THF under 70 °C using dibenzyl 
trithiocarbonate as chain transfer agent. The copolymers of VSI-co-ChMA and VSI-co-ChA with different 
content of cholesterol units were prepared using the variation of ratio of initial components in reaction 
mixture. To obtained the amphiphilic copolymers the alkaline hydrolysis of VSI units of VSI-co-Ch(M)A 
was carried out under mild conditions. The resulting copolymers consisted of N-vinylamido succinic acid 
(PVASA) moieties and cholesterol (metha)crylate segments. The synthesized copolymers were widely 
characterized using a set of physicochemical methods, namely gel-permeation chromatography NMR 
spectroscopy and TGA.  
The preparation of nanoparticles from p(VASA-co-Ch(M)A) was performed via the phase 
inversion from organic solvent  to water followed by lyophilization and final dispersion of probe in a 
buffer of choice. The self-assembled polymer particles were analyzed in regards of their size, zeta 
potential and morphology by DLS and scanning TEM methods. Moreover, the cytotoxicity of p(VASA-
co-Ch(M)A) nanoparticles was evaluated by MTT-test. 
 
  
